Breastcancer.org Podcast

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, talks about four studies that were presented at the 2015 San Antonio Breast Cancer Symposium, December 8-12, including studies that offer encouraging news about treatment for women diagnosed with triple-negative disease and metastatic, HER2-positive breast cancer. Listen to the podcast to hear Dr. Wojc...

In this podcast, Marisa Weiss, M.D., Breastcancer.org’s chief medical officer, explains a study that looked at the effectiveness of Arimidex and tamoxifen for reducing risk after DCIS surgery and radiation, as well as the side effects of each medicine. The study was presented at the 2015 San Antonio Breast Cancer Symposium, December 8-12. Listen to the podcast to hear Dr. Weiss explain: what DCIS...

In this Breastcancer.org podcast, Marisa Weiss, M.D., Breastcancer.org’s chief medical officer, discusses a study examining survival rates after lumpectomy plus radiation or mastectomy for early-stage breast cancer. The study was presented at the 2015 San Antonio Breast Cancer Symposium Dec. 8-12. Listen to the podcast to hear Dr. Weiss explain: why lumpectomy plus radiation and mastectomy are bot...

Nancy Davidson, M.D., is director of the University of Pittsburgh Cancer Institute, where she also is a distinguished professor of medicine and associate vice chancellor for cancer research. She also serves as president-elect of the American Association for Cancer Research, the first and largest cancer research organization in the world. Dr. Davidson is a world-renowned breast cancer researcher wh...

Hope Rugo, M.D. is a medical oncologist specializing in breast cancer research and treatment. A professor of medicine at the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, Dr. Rugo is the director of the Breast Oncology Clinical Trials Program and is the lead researcher on a number of studies investigating new treatments for both early-stage and metastati...

Tracy Crane is a registered dietitian and senior research specialist at the University of Arizona Zuckerman College of Public Health. Her research focuses on diet, specifically studying diet quality and cancer risk. Tracy also has more than 15 years’ experience developing nutrition plans for cancer survivors, many of them breast cancer survivors. Listen to the podcast to hear Tracy discuss: why ob...

Courtney Bitz is a licensed clinical social worker who heads the Couples Coping with Cancer Together program for City of Hope, a comprehensive cancer center in Duarte, Calif. When a woman is diagnosed with breast cancer, research has shown that having a supportive partner is one of the most important factors in helping her cope. But partners may struggle with knowing what to say or how best to sup...

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, explains a study published in January 2016 suggesting that chemotherapy for breast cancer may increase the risk of common infections. Listen to the podcast to hear Dr. Wojciechowski talk about: how the immune system works how chemotherapy affects the immune system when women who will be undergoing chem...

Cristina Nixon is a licensed certified genetic counselor with the Cancer Risk Assessment and Genetics Program at Main Line Health in Pennsylvania. In addition to counseling patients, she also assists with research, including, most recently, a study looking at multi-gene panels in BRCA1/BRCA2 positive families. Cristina also has completed the City of Hope’s intensive course in cancer risk assessmen...

Cristina Nixon is a licensed certified genetic counselor with the Cancer Risk Assessment and Genetics Program at Main Line Health in Pennsylvania. In addition to counseling patients, she also assists with research, including most recently a study looking at multi-gene panels in BRCA1/BRCA2-positive families. Cristina also has completed the City of Hope’s intensive course in cancer risk assessment....

Cristina Nixon is a licensed certified genetic counselor with the Cancer Risk Assessment and Genetics Program at Main Line Health in Pennsylvania. In addition to counseling patients, she also assists with research, including most recently a study looking at multi-gene panels in BRCA1/BRCA2-positive families. Cristina also has completed the City of Hope’s intensive course in cancer risk assessment....

Dr. Alan Stolier is a surgeon at the Center for Restorative Breast Surgery in New Orleans. He has more than 35 years of experience in surgical oncology. He specializes in the surgical treatment of breast cancer and is a pioneer in the development of nipple-sparing mastectomy. Dr. Stolier also focuses on breast cancer genetics and the associated care of women who have a BRCA gene mutation. Listen t...

Dr. Alan Stolier is a surgeon at the Center for Restorative Breast Surgery in New Orleans. He has more than 35 years of experience in surgical oncology. He specializes in the surgical treatment of breast cancer and is a pioneer in the development of nipple-sparing mastectomy. Dr. Stolier also focuses on breast cancer genetics and the associated care of women who have a BRCA gene mutation. Listen t...

Lorell Hornbrook has a strong family history of breast cancer: Both her older sister and her father were diagnosed with breast cancer. Her father died at age 75 from treatment complications, a year after he was diagnosed. In 2014, at age 48, Lorell decided to have genetic testing to see if she had a gene mutation that dramatically increased her risk for breast cancer. When her test results came ba...

Kerry Osmond was 10 when her mother was diagnosed with breast cancer in 1990. When it became available, genetic testing for a mutation that raises the risk of breast cancer was strongly recommended for Kerry’s mom — in 2010 her mother tested positive for a BRCA2 mutation. Kerry knew that meant she had a 50-50 chance of having the same mutation. In 2012, she decided to have genetic testing and lear...

Mandi Seifert was 3 when her mother was diagnosed with breast cancer in 1990. When it became available, genetic testing for a mutation that raises the risk of breast cancer was strongly recommended for Mandi’s mom — in 2010 her mother tested positive for a BRCA2 mutation. Mandi knew that meant she had a 50-50 chance of having the same mutation. In 2013, she decided to have genetic testing and lear...